News

Company News

Industry News

To create an industrial chain, Huibang Biological will increase the research and development of IVD innovative products with its original ability, and continue to develop the raw material market

To create an industrial chain, Huibang Biological will increase the research and development of IVD innovative products with its original ability, and continue to develop the raw material market

Recently, Anhui Huibang Bioengineering Co., Ltd. (hereinafter referred to as "Huibang Bio") , an IVD manufacturer , announced the completion of the second strategic financing. This round of financing was jointly completed by Jiaxing Qihui and Saizhi Capital. The proceeds from the financing will be used to accelerate product development. Post-launch marketing.

28

2021-01

The journey is tens of thousands of miles, the wind is vigorous, and the heavy responsibility is imminent, and we will start again!

The journey is tens of thousands of miles, the wind is vigorous, and the heavy responsibility is imminent, and we will start again!

15

2021-01

Strong alliance and win-win development, Huibang Biotech completed the second round of strategic financing

Strong alliance and win-win development, Huibang Biotech completed the second round of strategic financing

On December 25, 2020, Huibang Biotechnology (Anhui Huibang Bioengineering Co., Ltd., referred to as "Huibang Biology") officially announced the completion of the second round of financing. The signing ceremony was held at the Management Committee of Hefei High-tech Zone. This round of financing was jointly completed by Jiaxing Qihui and Saizhi Capital, with an estimated market value of more than 300 million. It is worth mentioning that nine Huibang strategic partners and provincial agents from all over the country participated in the list of capital parties, which has added a strong guarantee to Huibang's take-off.

15

2021-01

The international first丨Huibang's new product was released, and well-known media rushed to report

The international first丨Huibang's new product was released, and well-known media rushed to report

At 9:30 a.m. on August 18, 2020, Huibang Biotech's new product launch conference was held at the Anhui Equity Exchange Center. Nearly 200 leaders and experts from all levels in Anhui, leaders of the national core operation team, strategic investors and the media, etc. Representatives from the field participate.

29

2020-10

In 2020, Hefei High-tech Zone's "Yangtze River Delta Regional Medical Device Registrant System" policy interpretation and theme seminar was successfully held

In 2020, Hefei High-tech Zone's "Yangtze River Delta Regional Medical Device Registrant System" policy interpretation and theme seminar was successfully held

On the morning of August 1, the 2020 Hefei High-tech Zone "Yangtze River Delta Regional Medical Device Registrant System" Policy Interpretation and Theme Seminar hosted by the Management Committee of Hefei High-tech Zone, hosted by the High-tech Zone Investment Promotion Bureau and High-tech Company, was held in the High-tech Zone Held in the conference hall on the first floor of Building B of the Management Committee. Zhu Dehong, deputy director of the Medical Device Production Supervision Division of Anhui Provincial Food and Drug Administration, Xiang Min, member of the Working Committee and deputy director of the Management Committee of Hefei High-tech Zone, the person in charge of the Investment Promotion Bureau of the High-tech Zone, and the person in charge of Gaochuang shares attended the meeting. More than 60 corporate executives from the medical technology and medical device industries in the high-tech zone attended the meeting.

03

2020-08

Mr. Ji Junqiu, chairman of Lifang Pharmaceutical, visited Huibang Biology

Mr. Ji Junqiu, chairman of Lifang Pharmaceutical, visited Huibang Biology

During the discussion, Mr. Wang first introduced Huibang's biological industry chain, core products, technological advantages, and future development plans. Then the delegation visited the Instrument Department, Reagent R&D Department and Monoclonal Antibody Center of Huibang Biotechnology. Mr. Ji Junqiu fully affirmed the work achievements of Huibang Biotech in the field of in vitro diagnostic reagent research and the development of the industrial chain model.

14

2020-05

Today, salute the angels! Tribute to the soldiers!

Today, salute the angels! Tribute to the soldiers!

12

2020-05

The Provincial Maternal and Children's Health Center went to the medical and health industry to conduct research

The Provincial Maternal and Children's Health Center went to the medical and health industry to conduct research

On March 27, Director Ji Guoping and Secretary Wu Shudong of the Provincial Women's and Children's Health Care Center went to Anhui Huibang Bioengineering Co., Ltd. for investigation.

30

2020-03

< 1...456...8 >